In vivo antitumor activity of Sindhis viral vectors

Journal of the National Cancer Institute

Volumn 94, Issue 23, 2002, Pages 1790-1802

  Tseng, Jen Chieh ^a   Levin, Brandi ^a   Hirano, T Tadamichi ^a   Yee, Herman ^a   Pampeno, Christine ^a   Meruelo, Daniel ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; CELL MARKER; INTERLEUKIN 12; LAMININ RECEPTOR; LUCIFERASE; SODIUM CHLORIDE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MAMMAL CELL; MOUSE; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINDBIS VIRUS; TISSUE SECTION; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA-GALACTOSIDASE; CRICETINAE; FACTOR VIII; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; KILLER CELLS, NATURAL; LAC OPERON; MICE; MICE, SCID; NEOPLASMS; REPLICON; SINDBIS VIRUS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037021654     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Di Ianni M, Di Florio S, Venditti G, Falzetti F, Mannoni P, Martelli MF, et al. T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. J Hematother Stem Cell Res 1999;8:645-52.
2. Morling FJ, Russell SJ. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Ther 1995;2:504-8.
3. Lam JS, Reeves ME, Cowherd R, Rosenberg SA, Hwu P. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum Gene Ther 1996;7:1415-22.
4. Kume A, Hashiyama M, Suda T, Ozawa K. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. Stem Cells 1999;17:226-32.
5. Thompson L. Gene therapy. Monkey tests spark safety review. Science 1992;257:1854.
6. Miyao Y, Ikenaka K, Kishima H, Tamura M, Nakamura K, Kurumi M, et al. FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum. Hum Gene Ther 1997;8:1575-83.
7. Russell DW, Berger MS, Miller AD. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 1995;6:635-41.
8. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med 1995;182:1345-55.
9. Ginsberg HS. The ups and downs of adenovirus vectors. Bull N Y Acad Med 1996;73:53-8.
10. Sparer TE, Wynn SG, Clark DJ, Kaplan JM, Cardoza LM, Wadsworth SC, et al. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J Virol 1997;71:2277-84.
11. Duncan SJ, Gordon FC, Gregory DW, McPhie JL, Postlethwaite R, White R, et al. Infection of mouse liver by human adenovirus type 5. J Gen Virol 1978;40:45-61.
12. Alemany R, Suzuki K, Curiel DT. Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 2000;81:2605-9.
13. Alemany R, Balague C, Curiel DT. Replicative adenoviruses for cancer therapy. Nat Biotechnol 2000;18:723-7.
14. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994;58:491-562.
15. Altman-Hamamdzic S, Groseclose C, Ma JX, Hamamdzic D, Vrindavanam NS, Middaugh LD, et al. Expression of beta-galactosidase in mouse brain: utilization of a novel noureplicative Sindbis virus vector as a neuronal gene delivery system. Gene Ther 1997;4:815-22.
16. Gwag BJ, Kim EY, Ryu BR, Won SJ, Ko HW, Oh YJ, et al. A neuron-specific gene transfer by a recombinant defective Sindbis virus. Brain Res Mol Brain Res 1998;63:53-61.
17. Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol 1993;67:6439-46.
18. Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 1991;9:1356-61.
19. Piper RC, Slot JW, Li G, Stahl PD, James DE. Recombinant Sindbis virus as an expression system for cell biology. Methods Cell Biol 1994;43 Pt A:55-78.
20. Tsuji M, Bergmann CC, Takita-Sonoda Y, Murata K, Rodrigues EG, Nussenzweig RS, et al. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol 1998;72:6907-10.
21. Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA, et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 1998;72:950-8.
22. Pugachev KV, Mason PW, Shope RE, Frey TK. Double-subgenomic Sindhis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology 1995;212:587-94.
23. Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 1989;243:1188-91.
24. Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology 1999;263:209-19.
25. Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith IF. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 1997;239:389-401.
26. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, et al. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther 2002;13:553-68.
27. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993;361:739-42.
28. Jan JT, Griffin DE. Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J Virol 1999;73:10296-302.
29. Jan JT, Chatterjee S, Griffin DE. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 2000;74:6425-32.
30. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 2000;74:1513-23.
31. Turrell MJ. Horizontal and vertical transmission of viruses by insect and tick vectors. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Boca Raton (FL): CRC Press, Inc.; 1988. p. 127-52.
32. Menard S, Tagliabue E, Colnaghi MI. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1998;52:137-45.
33. Viacava P, Naccarato AG, Collecchi P, Menard S, Castronovo V, Bevilacqua G. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. J Pathol 1997;182:36-44.
34. Martignone S, Menard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993;85:398-402.
35. Basolo F, Pollina L, Pacini F, Fontanini G, Menard S, Castronovo V, et al. Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study. Clin Cancer Res 1996;2:1777-80.
36. Sanjuan X, Fernandez PL, Miquel R, Munoz J, Castronovo V, Menard S, et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol 1996;179:376-80.
37. de Manzoni G, Verlato G, Tomezzoli A, Guglielmi A, Pelosi G, Ricci F, et al. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol 1998;28:534-7.
38. Pelosi G, Pasini F, Bresaola E, Bogina G, Pederzoli P, Biolo S, et al. High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours. J Pathol 1997;183:62-9.
39. van den Brule FA, Castronovo V, Menard S, Giavazzi R, Marzola M, Belotti D, et al. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur J Cancer 1996;32A:1598-602.
40. Taraboletti G, Belotti D, Giavazzi R, Sobel ME, Castronovo V. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J Natl Cancer Inst 1993; 85:235-40.
41. Ozaki I, Yamamoto K, Mizuta T, Kajihara S, Fukushima N, Setoguchi Y, et al. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 1998;43:837-42.
42. van den Brule FA, Buicu C, Berchuck A, Bast RC, Deprez M, Liu FT, et al. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol 1996;27:1185-91.
43. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 1992; 66:4992-5001.
44. Strauss JH, Wang KS, Schmaljohn AL, Kuhn RJ, Strauss EG. Host-cell receptors for Sindbis virus. Arch Virol Suppl 1994;9:473-84.
45. Ohno K, Sawai K, Iijima Y, Levin B, Meruelo D. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 1997;15:763-7.
46. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
47. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;178:1223-30.
48. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, et al. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol 1994;153:1697-706.
49. Takeda K, Seki S, Ogasawara K, Anzai R, Hashimoto W, Sugiura K, et al. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996; 156:3366-73.
50. Tsung K, Meko JB, Peplinski GR, Tsung YL, Norton JA. IL-12 induces T helper 1-directed antitumor response. J Immunol 1997;158:3359-65.
51. Byrnes AP, Griffin DE. Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol 2000;74:644-51.
52. Bernard KA, Klimstra WB, Johnston RE. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 2000; 276:93-103.
53. Klimstra WB, Ryman KD, Johnston RE. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 1998;72:7357-66.
54. Griffin DE. Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis 1976; 133:456-64.
55. Liotta LA, Horan Hand P, Rao CN, Bryant G, Barsky SH, Schlom J. Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. Exp Cell Res 1985;156:117-26.
56. Barsky SH, Rao CN, Hyams D, Liotta LA. Characterization of a laminin receptor from human breast carcinoma tissue. Breast Cancer Res Treat 1984;4:181-8.
57. Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA. Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci U S A 1983; 80:444-8.
58. Gumperz JE, Parham P. The enigma of the natural killer cell. Nature 1995;378:245-8.
59. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47: 187-376.